Evidence-Based Therapy
Mind-Body & Cycle Practice

CBT for Mood

A structured talk therapy program to manage anxiety, depression, and emotional changes during menopause.

Last updated:

CBT for Mood
Method at a Glance
EfficacyN/Atypical use
Duration6-8 weekly sessions
Cost$0–$200/per-act
ReversibilityReversible
STI ProtectionNo
ProviderClinical psychologists, licensed therapists, CBT-trained counselors
Clinical Reference

Full clinical details

Efficacy data, safety profile, regulatory status, and research evidence for this method class.

Efficacy Profile
N/A

A 2024 systematic review and meta-analysis of CBT for depression and sleep in climacteric women (9 RCTs, n=923) found a combined effect size of 3.55 (95% CI -5.48 to -1.61, P<.05) for depressive symptoms. Individual RCTs include a 2019 trial (n=80) showing significant reduction in depression scores over 6 months with group CBT (PMID 31041241) and a 2024 Korean trial (n=40) showing significant improvement in GAD-7 anxiety scores (PMID 39190949). Evidence is promising but limited by small sample sizes, heterogeneous CBT protocols, and few placebo-controlled designs. NAMS 2023 recommends CBT (Level I) and notes women with VMS and psychosocial complaints improved with CBT.

Clinical EvidenceGreen 2024 meta-analysis (J Clin Med, PMID 38251106)
Cost & Insurance
$0–$200/per-act

Cost varies widely. In-person or telehealth CBT with a licensed therapist typically costs $100-$200 per session, with 6-8 sessions standard. Many insurance plans cover CBT for depression and anxiety when delivered by a licensed provider. Employee Assistance Programs (EAPs) may offer free short-term sessions.

Insurance CoverageUsually
Duration & Reversibility
Typical Lifespan6-8 weekly sessions
Reversibility
Reversible
STI ProtectionNo
How It Works
Biological Mechanism

Cognitive Behavioral Therapy (CBT) for mood helps women identify and modify unhelpful thought patterns and behaviors that contribute to anxiety, depression, and emotional distress during the menopause transition. It combines cognitive restructuring (challenging negative automatic thoughts), behavioral activation (re-engaging in rewarding activities), stress management skills, and psychoeducation about menopause. Unlike medication, it does not alter hormones or neurotransmitters directly.

Regulatory Details
FDA Regulatory StatusEvidence-Based Therapy
Prescription RequiredOTC
Provider TypeClinical psychologists, licensed therapists, CBT-trained counselors
Supporting Your Body & What to Expect
  • Temporary increase in emotional distress when discussing difficult feelings (usually transient)
  • No physical side effects
Safety & Suitability
  • •Active suicidality (requires crisis-level psychiatric care, not outpatient CBT alone)
  • •Severe depression requiring immediate medication (CBT may be used alongside medication but not as sole treatment)
  • •Active mania or psychosis
Clinical Guidelines
NAMS

2023 Position Statement - CBT recommended (Level I); women with VMS and psychosocial complaints benefit

View Guideline
Editorial Curation

Clinical Commentary & Context

What it is

Cognitive Behavioral Therapy (CBT) for mood is a structured, evidence-based talk therapy used to treat anxiety, depression, and emotional distress. During the menopause transition, hormonal changes can amplify mood symptoms, and CBT helps by targeting the thought patterns and behaviors that maintain them. A typical program runs 6 to 8 weekly sessions and includes cognitive restructuring (identifying and challenging negative automatic thoughts), behavioral activation (re-engaging in rewarding activities), stress management skills, and psychoeducation about menopause. CBT does not involve medication and can be delivered in person, via telehealth, or in group settings.

How well it works

A 2024 systematic review and meta-analysis published in the Journal of Clinical Medicine examined 9 RCTs (n=923) of CBT for depression and sleep problems in climacteric women. It found a combined effect size of 3.55 (95% CI -5.48 to -1.61, P<.05) for depressive symptoms, meaning CBT significantly reduced depression compared to control conditions. Individual trials support this: a 2019 randomized controlled trial in India (n=80) found that group CBT significantly reduced depression scores over 6 months compared to a control group. A 2024 Korean trial (n=40) found CBT significantly improved anxiety (GAD-7) scores and overall menopausal symptom scores compared to treatment as usual.

The evidence base is promising but limited. Many trials are small, CBT protocols vary across studies, and few use a placebo or active control design, so the size of the benefit for menopause-related mood symptoms is still uncertain.

The Menopause Society (NAMS 2023) recommends cognitive behavioral therapy as a Level I intervention (good and consistent scientific evidence) and notes that women with vasomotor symptoms and psychosocial complaints improved with CBT. The American Psychiatric Association recognizes CBT as a first-line, evidence-based treatment for depression and anxiety disorders.

Side effects and cautions

CBT does not involve medication, so it has no physical side effects. Some people experience a temporary increase in emotional distress when discussing difficult feelings in early sessions, but this typically resolves as therapy progresses. CBT is not appropriate as a sole treatment for people with active suicidality, severe depression requiring immediate medication, or acute mania or psychosis. In those cases, CBT may be used alongside other treatments once the acute crisis is stabilized.

Where to get it

CBT for mood is delivered by clinical psychologists, licensed therapists, and CBT-trained counselors. It is available in person and via telehealth. Many insurance plans cover CBT for depression and anxiety when provided by a licensed clinician. Employee Assistance Programs (EAPs) through employers may offer free short-term counseling sessions.